Insider Buying: Diploma PLC (LON:DPLM) Insider Buys 500 Shares of Stock

Diploma PLC (LON:DPLM) insider Ian El-Mokadem bought 500 shares of the stock in a transaction dated Monday, March 24th. The shares were acquired at an average price of GBX 3,948 ($51.01) per share, for a total transaction of £19,740 ($25,507.17).

Diploma Trading Down 0.1 %

DPLM traded down GBX 2 ($0.03) during midday trading on Tuesday, reaching GBX 3,980 ($51.43). 250,617 shares of the company’s stock traded hands, compared to its average volume of 529,895. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The stock has a market capitalization of £5.31 billion, a price-to-earnings ratio of 45.75, a P/E/G ratio of 2.82 and a beta of 0.75. The firm has a fifty day moving average of GBX 4,388.20 and a two-hundred day moving average of GBX 4,381.82. Diploma PLC has a 52 week low of GBX 3,372 ($43.57) and a 52 week high of GBX 4,808 ($62.13).

Diploma Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were issued a GBX 42 ($0.54) dividend. This is an increase from Diploma’s previous dividend of $17.30. The ex-dividend date was Thursday, January 16th. This represents a yield of 0.93%. Diploma’s dividend payout ratio is 65.52%.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 4,370 ($56.47) to GBX 4,420 ($57.11) and gave the company a “neutral” rating in a research note on Tuesday, January 14th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of GBX 4,567.50 ($59.02).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.